Reaching the last one per cent: Progress and challenges in global polio eradication

Current Opinion in Virology

Volumn 2, Issue 2, 2012, Pages 188-198

  Kew, Olen ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE;

AFGHANISTAN; ARTICLE; ENDEMIC DISEASE; EPIDEMIC; ERADICATION THERAPY; INCIDENCE; INDIA; NIGERIA; PAKISTAN; POLIOMYELITIS; PRIORITY JOURNAL; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 84859491866     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2012.02.006     Document Type: Review

References (45)

1. World Health Organization Progress towards interrupting wild poliovirus transmission worldwide: January 2010-March 2011 Wkly Epidemiol Rec 86 2011 199 204
2. B. Aylward, and T. Yamada The polio endgame N Engl J Med 364 2011 2273 2275
3. C.A. de Quadros, J.K. Andrus, J.M. Olivé, C. Guerra de Macedo, and D.A. Henderson Polio eradication from the Western Hemisphere Annu Rev Public Health 13 1992 239 252
4. R.B. Aylward, and C. Maher Interrupting poliovirus transmission - new solutions to an old problem Biologicals 34 2006 133 139 (Pubitemid 43765785)
5. J. Smith, R. Leke, A. Adams, and R.H. Tangermann Certification of polio eradication: process and lessons learned Bull World Health Organ 82 2004 24 30 (Pubitemid 38220339)
6. N. Nathanson, and O.M. Kew From emergence to eradication: the epidemiology of poliomyelitis deconstructed Am J Epidemiol 172 2010 1213 1229
7. P.E.M. Fine, and I.A.M. Carneiro Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative Am J Epidemiol 150 1999 1001 1021 (Pubitemid 29531936)
8. O.M. Kew, V. Morris-Glasgow, M. Landaverde, C. Burns, J. Shaw, Z. Garib, J. André, E. Blackman, C.J. Freeman, and J. Jorba Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus Science 296 2002 356 359 (Pubitemid 34303692)
9. Centers for Disease Control and Prevention Update on vaccine-derived polioviruses - worldwide July 2009-June 2011 MMWR Morb Mortal Wkly Rep 60 2011 846 850
10. J.F. Modlin The bumpy road to polio eradication N Engl J Med 362 2010 2346 2349
11. Z.A. Bhutta The last mile in global poliomyelitis eradication Lancet 378 2011 549 552
12. Donaldson L, El Sayed N, Koplan J, Nduati R, Toole M, de Quadros C, Mogedal S, Singhal A: Third quarterly report of the independent monitoring board of the global polio eradication initiative, October 2011. http://www. polioeradication.org/Aboutus/Governance/IndependentMonitoringBoard/Reports.aspx.
13. I. Arita, and D.P. Francis Safe landing for global polio eradication: a perspective Vaccine 29 2011 8827 8834
14. S.L. Cochi, and R.W. Linkins The final phase of polio eradication: new vaccines and complex choices J Infect Dis 205 2012 169 171
15. T.J. John Poliomyelitis in India: prospects and problems of control Rev Infect Dis 6 1984 S438 S441
16. Centers for Disease Control and Prevention Progress toward poliomyelitis eradication - Afghanistan and Pakistan, January 2010-September 2011 MMWR Morb Mortal Wkly Rep 60 2011 1523 1527
17. K. Chumakov, and O. Kew The poliovirus eradication initiative E. Ehrenfeld, E. Domingo, R. Roos, The Picornaviruses 2010 ASM Press 449 459
18. Centers for Disease Control and Prevention Apparent global interruption of wild poliovirus type 2 transmission MMWR Morb Mortal Wkly Rep 50 2001 222 224
19. R.W. Sutter, T.J. John, H. Jain, S. Agarkhedkar, P.V. Ramanan, H. Verma, J. Deshpande, A.P. Singh, M. Sreevatsava, and P. Malankar Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial Lancet 376 2010 1682 1688
20. Centers for Disease Control and Prevention Progress toward poliomyelitis eradication - India, January 2010-September 2011 MMWR Morb Mortal Wkly Rep 60 2011 1482 1486
21. N.C. Grassly, C. Fraser, J. Wenger, J.M. Deshpande, R.W. Sutter, D.L. Heymann, and R.B. Aylward New strategies for the elimination of polio from India Science 314 2006 1150 1153 (Pubitemid 44789046)
22. Centers for Disease Control and Prevention Resurgence of wild poliovirus type 1 transmission and consequences of importation - 21 countries, 2002-2005 MMWR Morb Mortal Wkly Rep 55 2006 145 150
23. Centers for Disease Control and Prevention Progress toward poliomyelitis eradication - Nigeria, January 2010-June 2011 MMWR Morb Mortal Wkly Rep 60 2011 1053 1057
24. World Health Organization Poliomyelitis 1980, Parts 1 and 2 Wkly Epidemiol Rec 56 1981 329 332 337-341
25. Centers for Disease Control and Prevention Wild poliovirus type 1 and type 3 importations - 15 countries, Africa, 2008-2009 MMWR Morb Mortal Wkly Rep 58 2009 357 362
26. Centers for Disease Control and Prevention Outbreaks following wild poliovirus importations - Europe, Africa, and Asia, January 2009-September 2010 MMWR Morb Mortal Wkly Rep 59 2010 1393 1399
27. Centers for Disease Control and Prevention Progress toward interrupting wild poliovirus circulation in countries with reestablished transmission - Africa, 2009-2010 MMWR Morb Mortal Wkly Rep 60 2011 306 311
28. Centers for Disease Control and Prevention Notes from the field: Poliomyelitis outbreak - Republic of the Congo, September 2010-February 2011 MMWR Morb Mortal Wkly Rep 60 2011 312 313
29. O.M. Kew, R.W. Sutter, E.M. de Gourville, W.R. Dowdle, and M.A. Pallansch Vaccine-derived polioviruses and the endgame strategy for global polio eradication Annu Rev Microbiol 59 2005 587 635 (Pubitemid 41507443)
30. A. Wringe, P.E.M. Fine, R.W. Sutter, and O.M. Kew Estimating the extent of vaccine-derived poliovirus infection PLoS ONE 3 2008 e3433
31. M. Rakoto-Andrianarivelo, N. Gumede, S. Jegouic, J. Balanant, S.N. Andriamamonjy, S. Rabemanantsoa, M. Birmingham, B. Randriamanalina, L. Nkolomoni, and M. Venter Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar J Infect Dis 197 2008 1427 1435 (Pubitemid 351706467)
32. S. Wassilak, M.A. Pate, K. Wannemuehler, J. Jenks, C. Burns, P. Chenoweth, E.A. Abanida, F. Adu, M. Baba, and A. Gasasira Outbreak of type 2 vaccine-derived poliovirus in Nigeria: 2005-2009: emergence and widespread circulation in an underimmunized population J Infect Dis 203 2011 898 909
33. H.E. Jenkins, R.B. Aylward, A. Gasasira, C.A. Donnelly, M. Mwanza, S. Garnier, C. Chauvin, E. Abanida, M.A. Pate, and F. Adu Implications of a circulating vaccine-derived poliovirus in Nigeria N Engl J Med 362 2010 2360 2369
34. P.A. Patriarca, R.W. Sutter, and P.M. Oostvogel Outbreaks of paralytic poliomyelitis, 1976-1995 J Infect Dis 175 Suppl. 1 1997 S165 S172 (Pubitemid 27053504)
35. K.M. Thompson, and R.J. Duintjer Tebbens Eradication versus control for poliomyelitis: an economic analysis Lancet 369 2007 1363 1371 (Pubitemid 46590365)
36. B.A. Brown, M.S. Oberste, K. Maher, and M. Pallansch Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the non-capsid coding region J Virol 77 2003 8973 8984 (Pubitemid 36936107)
37. Centers for Disease Control and Prevention Laboratory surveillance for wild and vaccine-derived polioviruses - worldwide, January 2008-June 2009 MMWR Morb Mortal Wkly Rep 58 2009 950 954
38. D.R. Kilpatrick, C.-F. Yang, K. Ching, A. Vincent, J. Iber, R. Campagnoli, M. Mandelbaum, L. De, S.-J. Yang, and A. Nix Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues J Clin Microbiol 47 2009 1939 1941
39. Centers for Disease Control and Prevention Tracking progress toward global polio eradication - worldwide, 2009-2010 MMWR Morb Mortal Wkly Rep 60 2011 441 445
40. J. Jorba, R. Campagnoli, L. De, and O. Kew Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range J Virol 82 2008 4429 4440 (Pubitemid 351563679)
41. J. Martín, G. Dunn, R. Hull, V. Patel, and P.D. Minor Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion J Virol 74 2000 3001 3010 (Pubitemid 30143722)
42. C.-F. Yang, H.-Y. Chen, J. Jorba, H.-C. Sun, S.-J. Yang, H.-C. Lee, Y.-C. Huang, T.-Y. Lin, P.-J. Chen, and H. Shimizu Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient J Virol 79 2005 12623 12634 (Pubitemid 41433181)
43. Centers for Disease Control and Prevention Update on vaccine-derived polioviruses - worldwide, January 2008-June 2009 MMWR Morb Mortal Wkly Rep 58 2009 1002 1006
44. C. MacLennan, G. Dunn, A.P. Huissoon, D.S. Kumararatne, J. Martín, P. O'Leary, R.A. Thompson, H. Osman, P. Wood, and P. Minor Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man Lancet 363 2004 1509 1513 (Pubitemid 38596828)
45. A.S. DeVries, J. Harper, A. Murray, C. Lexau, L. Bahta, J. Christensen, E. Cebelinski, S. Fuller, S. Kline, and G.S. Wallace Vaccine-derived poliomyelitis 12 years after infection in Minnesota N Engl J Med 364 2011 2316 2323